CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Total net sales	$ 1,027	$ 874
Cost of products sold	448	406
Gross profit	579	468
Selling, general, and administrative expenses	385	359
Research and development expenses	37	34
Goodwill impairment	0	157
Restructuring and other costs	3	43
Operating income (loss)	154	(125)
Other income and expenses:
Interest expense, net	14	7
Other expense (income), net	(9)	(2)
Income (loss) before income taxes	149	(130)
Provision for income taxes	32	10
Net income (loss)	117	(140)
Net Income (Loss) Attributable to Noncontrolling Interest	0	0
Net income (loss) attributable to Dentsply Sirona	$ 117	$ (140)
Net income (loss) per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ 0.53	$ (0.63)
Diluted (in dollars per share)	$ 0.53	$ (0.63)
Weighted average common shares outstanding:
Basic (in shares)	218.8	220.9
Diluted (in shares)	219.9	220.9

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227